- Home
- BPMC vs BBWI Comparison
BPMC vs BBWI Comparison
Compare BPMC & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- BBWI
- Stock Information
- Founded
- BPMC 2008
- BBWI 1963
- Country
- BPMC United States
- BBWI United States
- Employees
- BPMC N/A
- BBWI N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- BBWI Clothing/Shoe/Accessory Stores
- Sector
- BPMC Health Care
- BBWI Consumer Discretionary
- Exchange
- BPMC Nasdaq
- BBWI Nasdaq
- Market Cap
- BPMC 5.8B
- BBWI 6.1B
- IPO Year
- BPMC 2015
- BBWI N/A
- Fundamental
- Price
- BPMC $84.69
- BBWI $28.42
- Analyst Decision
- BPMC Buy
- BBWI Buy
- Analyst Count
- BPMC 22
- BBWI 18
- Target Price
- BPMC $124.48
- BBWI $43.12
- AVG Volume (30 Days)
- BPMC 1.2M
- BBWI 8.2M
- Earning Date
- BPMC 05-01-2025
- BBWI 06-03-2025
- Dividend Yield
- BPMC N/A
- BBWI 2.82%
- EPS Growth
- BPMC N/A
- BBWI N/A
- EPS
- BPMC N/A
- BBWI 3.61
- Revenue
- BPMC $508,824,000.00
- BBWI $7,307,000,000.00
- Revenue This Year
- BPMC $45.70
- BBWI $4.63
- Revenue Next Year
- BPMC $31.83
- BBWI $3.02
- P/E Ratio
- BPMC N/A
- BBWI $7.87
- Revenue Growth
- BPMC 104.04
- BBWI N/A
- 52 Week Low
- BPMC $73.04
- BBWI $24.96
- 52 Week High
- BPMC $121.90
- BBWI $52.99
- Technical
- Relative Strength Index (RSI)
- BPMC 47.15
- BBWI 45.60
- Support Level
- BPMC $78.66
- BBWI $27.09
- Resistance Level
- BPMC $83.50
- BBWI $28.89
- Average True Range (ATR)
- BPMC 5.00
- BBWI 2.06
- MACD
- BPMC 0.20
- BBWI 0.13
- Stochastic Oscillator
- BPMC 67.15
- BBWI 48.80
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.